{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:27:40Z","timestamp":1784136460895,"version":"3.55.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"United States Department of Veterans Affairs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journalofpsychiatricresearch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jpsychires.2015.07.016","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T16:44:35Z","timestamp":1437583475000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8977-4779","authenticated-orcid":false,"given":"Anna D.","family":"Rubinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Batki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpsychires.2015.07.016_bib1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.15288\/jsad.2009.70.628","article-title":"Counselor attitutdes toward pharmacotherapies for alcohol dependence","volume":"70","author":"Abraham","year":"2009","journal-title":"J\u00a0Stud Alcohol Drugs"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib3","series-title":"ASAM Patient Placement Criteria: Supplement on Pharmacotherapies for Alcohol Use Disorders","first-page":"79","article-title":"Strategies for preventing and managing relapse","author":"American Society of Addiction Medicine","year":"2012"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib4","first-page":"8","article-title":"Topiramate in the treatment of alcohol dependence: a meta-analysis","volume":"38","author":"Arbaizar","year":"2010","journal-title":"Actas Esp. Psiquiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-859X-4-5","article-title":"Review of the use of Topiramate for treatment of psychiatric disorders","volume":"4","author":"Arnone","year":"2005","journal-title":"Ann. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.07.016_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jsat.2008.06.003","article-title":"Smoking cessation during substance abuse treatment: what you need to know","volume":"36","author":"Baca","year":"2009","journal-title":"J.\u00a0Subst. Abuse Treat."},{"issue":"Suppl.\u00a08","key":"10.1016\/j.jpsychires.2015.07.016_bib7","first-page":"S222","article-title":"Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence","volume":"17","author":"Baser","year":"2011","journal-title":"Am. J. Manag. Care"},{"issue":"3","key":"10.1016\/j.jpsychires.2015.07.016_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4088\/JCP.11m07311","article-title":"Prescribing trends in veterans with posttraumatic stress disorder","volume":"73","author":"Bernardy","year":"2012","journal-title":"J.\u00a0Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2015.07.016_bib9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/acer.12411","article-title":"A\u00a0meta-analysis of topiramate's effects for individuals with alcohol use disorders","volume":"38","author":"Blodgett","year":"2014","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"5","key":"10.1016\/j.jpsychires.2015.07.016_bib10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.amepre.2011.06.045","article-title":"Economic costs of excessive alcohol consumption in the U.S., 2006","volume":"41","author":"Bouchery","year":"2011","journal-title":"Am. J. Prev. Med."},{"issue":"2","key":"10.1016\/j.jpsychires.2015.07.016_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0740-5472(00)00094-5","article-title":"Treating substance abuse in the context of severe and persistent mental illness: clinicians' perspectives","volume":"19","author":"Carey","year":"2000","journal-title":"J.\u00a0Subst. Abuse Treat."},{"key":"10.1016\/j.jpsychires.2015.07.016_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1940-0640-8-12","article-title":"Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration","volume":"8","author":"Del Re","year":"2013","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2015.07.016_bib13","series-title":"VHA Handbook 1160.01: Uniform Mental Health Services in VA Medical Centers and Clinics","author":"Department of Veterans Affairs","year":"2008"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib14","series-title":"The Management of MDD Working Group. VA\/DoD Clinical Practice Guideline for Management of Major Depressive Disorder (MDD)","author":"Department of Veterans Affairs (VA) and Department of Defense (DoD)","year":"2009"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib15","series-title":"The Management of Substance Use Disorders Working Group. VA\/DoD Clinical Practice Guideline for Management of Substance Use Disorders (SUD)","author":"Department of Veterans Affairs (VA) and Department of Defense (DoD)","year":"2009"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib16","series-title":"The Management of Post-Traumatic Stress Working Group. VA\/DoD Clinical Practice Guideline for Management of Post-Traumatic Stress","author":"Deparment of Veterans Affairs (VA) and Department of Defense (DoD)","year":"2010"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib17","series-title":"The Management of Bipolar Disorder Working Group. VA\/DoD Clinical Practice Guideline for Management of Bipolar Disorder in Adults","author":"Deparment of Veterans Affairs (VA) and Department of Defense (DoD)","year":"2010"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib18","unstructured":"Department of Veterans Affairs (VA) and Department of Defense (DoD). VA\/DoD Clinical Practice Guidelines 810 Vermont Avenue, NW Washington DC 20420: U.S. Department of Veterans Affairs. Available from: http:\/\/www.healthquality.va.gov."},{"issue":"4","key":"10.1016\/j.jpsychires.2015.07.016_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.15288\/jsad.2012.73.635","article-title":"Who seeks care where? Utilization of mental health and substance use disorder treatment in two national samples of individuals with alcohol use disorders","volume":"73","author":"Edlund","year":"2012","journal-title":"J.\u00a0Stud. Alcohol Drugs"},{"issue":"3","key":"10.1016\/j.jpsychires.2015.07.016_bib20","first-page":"162","article-title":"An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"29","author":"Falk","year":"2006","journal-title":"Alcohol Res. Health"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jsat.2011.07.005","article-title":"Comparing alternative specifications of quality measures: access to pharmacotherapy for alcohol use disorders","volume":"42","author":"Fernandes-Taylor","year":"2012","journal-title":"J.\u00a0Subst. Abuse Treat."},{"issue":"6","key":"10.1016\/j.jpsychires.2015.07.016_bib22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/add.12105","article-title":"Tobacco dependence diagnosis and treatment in Veterans Health Administration residential substance use disorder treatment programs","volume":"108","author":"Gifford","year":"2013","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jpsychires.2015.07.016_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2004.02.004","article-title":"The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002","volume":"74","author":"Grant","year":"2004","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.jpsychires.2015.07.016_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7205\/MILMED-D-00-3108","article-title":"Evidence-based national initiatives to address tobacco use as a public health priority in the Veterans Health Administration","volume":"174","author":"Hamlett-Berry","year":"2009","journal-title":"Mil. Med."},{"issue":"10","key":"10.1016\/j.jpsychires.2015.07.016_bib26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1176\/ps.2008.59.10.1121","article-title":"Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants","volume":"59","author":"Hansen","year":"2008","journal-title":"Psychiatr. Serv."},{"issue":"4","key":"10.1016\/j.jpsychires.2015.07.016_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1176\/ps.2010.61.4.392","article-title":"Pharmacotherapy of alcohol use disorders in the Veterans Health Administration","volume":"61","author":"Harris","year":"2010","journal-title":"Psychiatr. Serv."},{"issue":"7","key":"10.1016\/j.jpsychires.2015.07.016_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1176\/appi.ps.201000553","article-title":"Pharmacotherapy of alcohol use disorders in the Veterans Health Administration: patterns of receipt and persistence","volume":"63","author":"Harris","year":"2012","journal-title":"Psychiatr. Serv."},{"issue":"4","key":"10.1016\/j.jpsychires.2015.07.016_bib29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1037\/a0030949","article-title":"Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers","volume":"10","author":"Harris","year":"2013","journal-title":"Psychol. Serv."},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2015.07.016_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugalcdep.2013.01.016","article-title":"Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study","volume":"132","author":"Iheanacho","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"18","key":"10.1016\/j.jpsychires.2015.07.016_bib31","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"3\u20134","key":"10.1016\/j.jpsychires.2015.07.016_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/19371918.2013.774673","article-title":"Integrated treatment of substance use and psychiatric disorders","volume":"28","author":"Kelly","year":"2013","journal-title":"Soc. Work Public Health"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.addbeh.2011.09.010","article-title":"Treatment of substance abusing patients with comorbid psychiatric disorders","volume":"37","author":"Kelly","year":"2012","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1037\/h0080151","article-title":"The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization","volume":"66","author":"Kessler","year":"1996","journal-title":"Am. J. Orthopsychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2015.07.016_bib35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2015.07.016_bib36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1176\/appi.ps.56.12.1549","article-title":"Racial differences in the treatment of veterans with bipolar disorder","volume":"56","author":"Kilbourne","year":"2005","journal-title":"Psychiatr. Serv."},{"issue":"2","key":"10.1016\/j.jpsychires.2015.07.016_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ADM.0b013e3181b41a32","article-title":"Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations","volume":"4","author":"Knudsen","year":"2010","journal-title":"J.\u00a0Addict. Med."},{"issue":"11","key":"10.1016\/j.jpsychires.2015.07.016_bib38","first-page":"858","article-title":"The treatment gap in mental health care","volume":"82","author":"Kohn","year":"2004","journal-title":"Bull. World Health Organ."},{"issue":"3","key":"10.1016\/j.jpsychires.2015.07.016_bib39","first-page":"113","article-title":"Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector","volume":"6","author":"Leslie","year":"2003","journal-title":"J.\u00a0Ment. Health Policy Econ."},{"issue":"9896","key":"10.1016\/j.jpsychires.2015.07.016_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2015.07.016_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.drugalcdep.2008.07.018","article-title":"Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty","volume":"99","author":"Mark","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.jpsychires.2015.07.016_bib42","first-page":"879","article-title":"Comparison of healthcare utilization among patients treated with alcoholism medications","volume":"16","author":"Mark","year":"2010","journal-title":"Am. J. Manag. Care"},{"issue":"13","key":"10.1016\/j.jpsychires.2015.07.016_bib43","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jpsychires.2015.07.016_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/YCO.0b013e3281c61dc5","article-title":"Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys","volume":"20","author":"Merikangas","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"issue":"9426","key":"10.1016\/j.jpsychires.2015.07.016_bib45","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","volume":"363","author":"Mueser","year":"2004","journal-title":"Schizophr. Lancet"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib46","volume":"vol. 2","author":"National Committee for Quality Assurance","year":"2013"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib47","series-title":"Helping Patients Who Drink Too Much: a Clinician's Guide","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2007"},{"issue":"10","key":"10.1016\/j.jpsychires.2015.07.016_bib48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.biopsych.2004.10.002","article-title":"Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action","volume":"56","author":"O'Brien","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2015.07.016_bib49","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11920-011-0222-2","article-title":"Barriers to use of pharmacotherapy for addiction disorders and how to overcome them","volume":"13","author":"Oliva","year":"2011","journal-title":"Curr. Psychiatry Rep."},{"issue":"2","key":"10.1016\/j.jpsychires.2015.07.016_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00952990.2012.741167","article-title":"Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand?","volume":"39","author":"Oliva","year":"2013","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.07.016_bib51","first-page":"81","article-title":"Comorbidity of alcoholism and psychiatric disorders: an overview","volume":"26","author":"Petrakis","year":"2002","journal-title":"Alcohol Res. Health"},{"issue":"4","key":"10.1016\/j.jpsychires.2015.07.016_bib52","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/acer.12331","article-title":"Burden of disease associated with alcohol use disorders in the United States","volume":"38","author":"Rehm","year":"2014","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.jpsychires.2015.07.016_bib53","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.addbeh.2011.01.032","article-title":"Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation","volume":"36","author":"Roman","year":"2011","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2005.06.014","article-title":"Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs","volume":"108","author":"Saxon","year":"2005","journal-title":"Pharmacol. Ther."},{"issue":"9662","key":"10.1016\/j.jpsychires.2015.07.016_bib55","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0140-6736(09)60009-X","article-title":"Alcohol-use disorders","volume":"373","author":"Schuckit","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.07.016_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0033-1363258","article-title":"Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics","volume":"47","author":"Selle","year":"2014","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.07.016_bib57","doi-asserted-by":"crossref","first-page":"e87366","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis","volume":"9","author":"Skinner","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jpsychires.2015.07.016_bib58","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/tc.2009.035147","article-title":"Using policy to increase prescribing of smoking cessation medications in the VA healthcare system","volume":"19","author":"Smith","year":"2010","journal-title":"Tob. Control"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib59","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.5888\/pcd11.130293","article-title":"Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States","volume":"11","author":"Stahre","year":"2014","journal-title":"Prev. Chronic Dis."},{"key":"10.1016\/j.jpsychires.2015.07.016_bib60","series-title":"Stata Statistical Software: Release 13","author":"StataCorp","year":"2013"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000146.pub4","article-title":"Nicotine replacement therapy for smoking cessation","volume":"11","author":"Stead","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002795.pub2","article-title":"Pharmacotherapy for post traumatic stress disorder (PTSD)","author":"Stein","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2005.03.009","article-title":"Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"80","author":"Stinson","year":"2005","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.jpsychires.2015.07.016_bib64","doi-asserted-by":"crossref","first-page":"804","DOI":"10.2146\/ajhp120222","article-title":"Medication acquisition across systems of care and patient-provider communication among older veterans","volume":"70","author":"Stroupe","year":"2013","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"2","key":"10.1016\/j.jpsychires.2015.07.016_bib65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/alcalc\/agl100","article-title":"Knowledge and attitudes about pharmacotherapy for alcoholism: a survey of counselors and administrators in community-based addiction treatment centres","volume":"42","author":"Thomas","year":"2007","journal-title":"Alcohol Alcohol."},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsat.2013.01.004","article-title":"Establishing the feasibility of measuring performance in use of addiction pharmacotherapy","volume":"45","author":"Thomas","year":"2013","journal-title":"J.\u00a0Subst. Abuse Treat."},{"issue":"4","key":"10.1016\/j.jpsychires.2015.07.016_bib67","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1530-0277.2007.00336.x","article-title":"Treatments for patients with dual diagnosis: a review","volume":"31","author":"Tiet","year":"2007","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.jpsychires.2015.07.016_bib68","series-title":"Treating Tobacco Use and Dependence: 2008 Update","author":"Tobacco Use and Dependence Guideline Panel","year":"2008"},{"issue":"3 Suppl.\u00a01","key":"10.1016\/j.jpsychires.2015.07.016_bib69","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/MLR.0b013e31827da836","article-title":"VHA mental health information system: applying health information technology to monitor and facilitate implementation of VHA Uniform Mental Health Services Handbook requirements","volume":"51","author":"Trafton","year":"2013","journal-title":"Med. Care"},{"key":"10.1016\/j.jpsychires.2015.07.016_bib70","series-title":"Improvements Needed in Monitoring Antidepressant Use for Major Depressive Disorder and in Increasing Accuracy of Suicide Data","author":"U.S. Government Accountability Office","year":"2014"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib71","article-title":"Topiramate for acute affective episodes in bipolar disorder","author":"Vasudev","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2015.07.016_bib72","series-title":"Clinical Practice Guideline for the Management of Person with Psychosis","author":"Veterans Health Administration (VHA)","year":"2001"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.07.016_bib73","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12913-014-0490-8","article-title":"Patient perspectives on having multiple versus single prescribers of chronic disease medications: results of a qualitative study in a veteran population","volume":"14","author":"Voils","year":"2014","journal-title":"BMC Health Serv. Res."},{"issue":"9","key":"10.1016\/j.jpsychires.2015.07.016_bib74","doi-asserted-by":"crossref","first-page":"743","DOI":"10.7326\/0003-4819-132-9-200005020-00011","article-title":"A\u00a0systematic review of newer pharmacotherapies for depression in adults: evidence report summary","volume":"132","author":"Williams","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jpsychires.2015.07.016_bib75","series-title":"Addictive Disorders in Medical Populations","article-title":"Addictive disorders in psychiatric medicine","author":"Yuodelis-Flores","year":"2010"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395615002095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395615002095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T11:56:56Z","timestamp":1691841416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395615002095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":75,"alternative-id":["S0022395615002095"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.07.016","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}